Sandy Spring Bank’s Standard BioTools LAB Stock Holding History

Sandy Spring Bank’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.08K	Hold	1,000	–	–	﹤0.01%	1087
2024 Q4	$1.75K	Hold	1,000	–	–	﹤0.01%	1074
2024 Q3	$1.93K	Hold	1,000	–	–	﹤0.01%	1037
2024 Q2	$1.77K	Hold	1,000	–	–	﹤0.01%	1108
2024 Q1	$2.71K	Hold	1,000	–	–	﹤0.01%	1019
2023 Q4	$2.21K	Hold	1,000	–	–	﹤0.01%	1011
2023 Q3	$2.9K	Hold	1,000	–	–	﹤0.01%	996
2023 Q2	$1.93K	Hold	1,000	–	–	﹤0.01%	1070
2023 Q1	$1.95K	Hold	1,000	–	–	﹤0.01%	1025
2022 Q4	$1.17K	Hold	1,000	–	–	﹤0.01%	1054
2022 Q3	$1K	Hold	1,000	–	–	﹤0.01%	1094
2022 Q2	$2K	Hold	1,000	–	–	﹤0.01%	1053
2022 Q1	$4K	Hold	1,000	–	–	﹤0.01%	993
2021 Q4	$4K	Buy	1,000 +500	+100%	+$2.34K	﹤0.01%	1054
2021 Q3	$3K	Sell	500 -200	-29%	-$1.32K	﹤0.01%	1024
2021 Q2	$4K	Sell	700 -300	-30%	-$1.6K	﹤0.01%	1003
2021 Q1	$5K	Buy	1,000 +100	+11%	+$549	﹤0.01%	874
2020 Q4	$5K	Buy	900 +400	+80%	+$2.63K	﹤0.01%	823
2020 Q3	$4K	Buy	500 +200	+67%	+$1.38K	﹤0.01%	765
2020 Q2	$1K	Sell	300 -230	-43%	-$801	﹤0.01%	864
2020 Q1	$1K	Buy	+530	New	+$1.74K	﹤0.01%	867

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sandy Spring Bank's LAB Position: Q1 2025 in Review

Sandy Spring Bank held its Standard BioTools (LAB) position steady in Q1 2025 at 1,000 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Sandy Spring Bank first reported a position in LAB in Q1 2020 and has held it in 21 quarters since. The position peaked at $5K in Q1 2021. 145 funds tracked by Wall St. Rank hold LAB as of Q1 2025.

Sandy Spring Bank held 1,000 shares of Standard BioTools worth $1.08K as of Q1 2025.
Sandy Spring Bank left its Standard BioTools share count unchanged in Q1 2025.
Standard BioTools made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #1087 holding.
Sandy Spring Bank first reported a position in Standard BioTools in Q1 2020 and has held it in 21 quarters since.
Sandy Spring Bank's Standard BioTools position peaked at $5K in Q1 2021.
145 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.